Whitehawk Therapeutics (WHWK) Share-based Compensation Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.70% |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - | 30.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.54% |
| Dec 31, 2025 | 28.80% |
| Sep 30, 2025 | 6.30% |
| Jun 30, 2025 | 8.74% |
| Mar 31, 2025 | -53.19% |
| Dec 31, 2024 | -40.41% |
| Sep 30, 2024 | -16.14% |
| Jun 30, 2024 | -7.04% |
| Mar 31, 2024 | 30.99% |
| Dec 31, 2023 | 8.40% |
| Sep 30, 2023 | 10.59% |
| Jun 30, 2023 | 36.64% |
| Mar 31, 2023 | 53.85% |
| Dec 31, 2022 | 107.52% |
| Sep 30, 2022 | 325.46% |
| Jun 30, 2022 | 5,630.77% |
| Mar 31, 2022 | 4,847.22% |
| Dec 31, 2021 | 3,446.15% |
| Sep 30, 2021 | 1,805.88% |
| Jun 30, 2021 | -87.35% |
| Mar 31, 2021 | -89.01% |
| Dec 31, 2020 | 104.96% |
| Sep 30, 2020 | -94.74% |
| Jun 30, 2020 | -49.01% |
| Mar 31, 2020 | -47.33% |
| Dec 31, 2019 | -217.73% |
| Sep 30, 2019 | -19.90% |
| Jun 30, 2019 | -31.11% |
| Mar 31, 2019 | -42.42% |
| Dec 31, 2018 | 161.81% |
| Sep 30, 2018 | 533.18% |
| Jun 30, 2018 | 687.06% |
| Mar 31, 2018 | 594.87% |
| Dec 31, 2017 | 96.17% |
| Sep 30, 2017 | 12.21% |
| Jun 30, 2017 | -6.71% |
| Mar 31, 2017 | 24.09% |